These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6673551)

  • 1. [Effects of intravitreal injection of urokinase on the rabbit eye. II. Effects of urokinase with stabilizer on ERP amplitude].
    Tamai A; Ueno H; Noda K; Kishi S; Iyota K; Masaoka N; Wada H
    Nippon Ganka Gakkai Zasshi; 1983; 87(10):974-82. PubMed ID: 6673551
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Men G; Peyman GA; Genaidy M; Kuo PC; Ghahramani F; Blake DA; Bezerra Y; Naaman G; Figueiredo E
    Retina; 2004 Apr; 24(2):199-209. PubMed ID: 15097878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intravitreal injections of distilled water, air and urokinase in the management of recurrent vitreous haemorrhage.
    Chattopadhyay PR; Jain IS; Dhir SP; Sharma RR
    Indian J Ophthalmol; 1982 May; 30(3):143-6. PubMed ID: 7174058
    [No Abstract]   [Full Text] [Related]  

  • 4. Urokinase in experimental vitreous hemorrhage.
    Koziol J; Peyman GA; Sanders DR; Vichek J; Goldberg MF
    Ophthalmic Surg; 1975; 6(3):79-82. PubMed ID: 810755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravitreal urokinase for vitreous hemorrhage].
    Kolácek K
    Cesk Oftalmol; 1983 Jan; 39(1):29-32. PubMed ID: 6339087
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal urokinase in the treatment of vitreous haemorrhage.
    Cleary PE; Davies EW; Shilling JS; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):587-90. PubMed ID: 4534195
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal urokinase in the management of vitreous haemorrhage.
    Sellors PJ; Kanski JJ; Watson DM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):591-8. PubMed ID: 4534196
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of fibrinolysis in the vitreous body.
    Pandolfi M
    Bibl Anat; 1979; (18):292-7. PubMed ID: 159041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subconjunctival injection of urokinase in the treatment of diabetic vitreous hemorrhage].
    Chen XL
    Zhonghua Yan Ke Za Zhi; 1983 Jan; 19(1):35-6. PubMed ID: 6406190
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Gandorfer A; Kampik A
    Retina; 2005; 25(2):232-3; author reply 233-4. PubMed ID: 15689824
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-treatment of fresh laser irradiation-induced vitreous hemorrhage.
    Belkin M; Lund DJ; Beatrice ES
    Ophthalmologica; 1983; 187(3):152-6. PubMed ID: 6634062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
    Bode C; Runge M; Eberle T; Freitag M; Kübler W; Haber E
    Trans Assoc Am Physicians; 1989; 102():7-12. PubMed ID: 2517856
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of the thrombolytic effect of low urokinase concentrations.
    Matsuo O; Mihara H; Rokushima Y
    Nihon Ketsueki Gakkai Zasshi; 1976 Jun; 39(3):298-305. PubMed ID: 990007
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits.
    Hisano S; Sueishi K; Ishii Y; Tanaka K
    Thromb Haemost; 1979 Jun; 41(4):796-803. PubMed ID: 483251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravitreal injection of bevacizumab in rabbit eyes.
    Feiner L; Barr EE; Shui YB; Holekamp NM; Brantley MA
    Retina; 2006 Oct; 26(8):882-8. PubMed ID: 17031287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreoretinal toxicity of acetazolamide following intravitreal administration in the rabbit eye.
    Borhani H; Rahimy MH; Peyman GA
    Ophthalmic Surg; 1994 Mar; 25(3):166-9. PubMed ID: 8196921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina.
    Dierks D; Lei B; Zhang K; Hainsworth DP
    Arch Ophthalmol; 2005 Nov; 123(11):1563-9. PubMed ID: 16286619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.